Squarepoint Ops LLC Invests $147,000 in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Squarepoint Ops LLC bought a new stake in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 15,256 shares of the company’s stock, valued at approximately $147,000.

Several other hedge funds have also added to or reduced their stakes in STXS. Captrust Financial Advisors bought a new position in shares of Stereotaxis during the 1st quarter valued at $57,000. Cubist Systematic Strategies LLC bought a new position in shares of Stereotaxis during the 1st quarter valued at $100,000. Campbell & CO Investment Adviser LLC bought a new position in shares of Stereotaxis during the 2nd quarter valued at $101,000. Price T Rowe Associates Inc. MD bought a new position in shares of Stereotaxis during the 1st quarter valued at $111,000. Finally, Jane Street Group LLC bought a new position in shares of Stereotaxis during the 1st quarter valued at $132,000. 67.76% of the stock is currently owned by institutional investors.

NYSEAMERICAN:STXS opened at $6.26 on Thursday. Stereotaxis, Inc. has a 12 month low of $4.20 and a 12 month high of $10.30. The stock has a market capitalization of $466.88 million, a PE ratio of -48.15 and a beta of 1.47.

Stereotaxis (NYSEAMERICAN:STXS) last issued its quarterly earnings results on Thursday, November 11th. The company reported ($0.07) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.03). Stereotaxis had a negative return on equity of 24.21% and a negative net margin of 25.42%. As a group, research analysts predict that Stereotaxis, Inc. will post -0.14 earnings per share for the current year.

Separately, Zacks Investment Research cut shares of Stereotaxis from a “hold” rating to a “strong sell” rating in a research report on Wednesday, November 17th.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures and markets robotic magnetic navigation systems for use in a hospital’s interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System.

See Also: What is the Fibonacci sequence?

Want to see what other hedge funds are holding STXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stereotaxis, Inc. (NYSEAMERICAN:STXS).

Institutional Ownership by Quarter for Stereotaxis (NYSEAMERICAN:STXS)

Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.com's FREE daily email newsletter.